EP3551617
Samsetningar og aðferðir sem tengjast pýridínóýlpíperidín 5-HT1F gerandefnum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.12.2017EP published:
11.8.2021EP application number:
17829372.6
EP translation filed:
9.9.2021Grant published:
15.10.2021EPO information:
European Patent Register
Max expiry date:
4.12.2037Expiry date:
4.12.2026Next due date:
31.12.2026
Title:
COMPOSITIONS AND METHODS RELATED TO PYRIDINOYLPIPERIDINE 5-HT1F AGONISTS
Timeline
Today
5.12.2017EP application
11.8.2021EP Publication
9.9.2021Translation submitted
15.10.2021Registration published
4.12.2026Expires
Owner
Name:
CoLucid Pharmaceuticals, Inc.Address:
c/o Eli Lilly and Company Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
ALLIERI, BrigidaAddress:
Indianapolis, IN 46285, US
Name:
FAGAN, PaulAddress:
Indianapolis, IN 46285, US
Name:
SHARP, EmmaAddress:
Cambridge Cambridgeshire CB4 0WE, GB
Name:
SKWIERCZYNSKI, Raymond, D.Address:
Indianapolis, IN 46285, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662430662 PDate:
6.12.2016Country:
US
Classification
Categories:
C07D 401/06, A61K 31/444, A61P 25/06
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 17.11.2021
Expires: 4.12.2022
Payer: Patice ehf.
Number: 6
Paid: 22.11.2022
Expires: 4.12.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 29.11.2023
Expires: 4.12.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 21.11.2024
Expires: 4.12.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 5.12.2025
Expires: 4.12.2026
Payer: Árnason Faktor ehf.